Novartis AG discloses no encumbrance on its 1.75 crore equity shares in Novartis India as of March 31, 2026.
Reiterates its agreement to sell its entire 70.68% stake to three acquirers, as per the February 19, 2026 SPA.
Filing is a mandatory disclosure under SEBI Takeover Regulations Regulation 31(4) by the promoter entity.